Chile SRS vac­cine ‘ground break­ing’

Fish Farmer - - News -

A VAC­CINE against SRS (salmon rick­ettsial sep­ti­caemia) has re­ceived mar­ket­ing au­tho­ri­sa­tion from the Chilean au­thor­i­ties, re­ported Phar­maq.

It said the ap­proval to sell the com­pany’s Al­pha Ject LiVac SRS vac­cine is a ma­jor tech­nol­ogy mile­stone for the fish farm­ing in­dus­try

Years of re­search, de­vel­op­ment and doc­u­men­ta­tion en­sure a high level of pro­tec­tion, as well as be­ing safe for the fish and the en­vi­ron­ment.

‘Our in­no­va­tive drive is based on the aqua­cul­ture in­dus­try’s need to pro­duce safe and healthy seafood,’ said Phar­maq pres­i­dent Morten Kr Nord­stad.

‘We are con­fi­dent that this ground break­ing vac­cine will be an im­por­tant tool to help fight SRS. This is a highly re­quested prod­uct by the in­dus­try and will help achieve more pre­dictable and re­li­able fish pro­duc­tion.’

SRS is con­sid­ered to be the most im­por­tant dis­ease prob­lem in the Chilean salmon farm­ing in­dus­try, af­fect­ing all three species farmed in Chile: At­lantic salmon, rain­bow trout and coho salmon.

Above: Vac­cine is ma­jor mile­stone for the in­dus­tryx

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.